Fed. Circ. Ruling Clears Path For Longer Drug Patent Terms
The Federal Circuit has given some patent owners, especially those in the pharmaceutical industry, a chance to obtain potentially lucrative extensions on the life of their patents by striking down U.S....To view the full article, register now.
Already a subscriber? Click here to view full article